Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

2 clinical studies listed.

Filters:

Spectroscopic Analysis

Tundra lists 2 Spectroscopic Analysis clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

NOT YET RECRUITING

NCT07577466

Screening, Characterization, and Longitudinal Follow-up of Patients With Cardiac Amyloidosis

Cardiac amyloidosis is a progressive disorder caused by extracellular deposition of amyloid fibrils in the heart, leading to heart failure and impaired cardiac function. Early diagnosis and targeted therapies are essential to improve patient outcomes. This prospective, single-center study aims to longitudinally follow patients with suspected cardiac amyloidosis to characterize disease progression and assess treatment effects. Participants will undergo cardiac magnetic resonance imaging (resting and exercise stress MRI), magnetic resonance spectroscopy, cardiopulmonary exercise testing (spiroergometry) and blood testing at baseline and at 6, 12, and 24 months

Gender: All

Ages: 18 Years - Any

Updated: 2026-05-11

1 state

Amyloidosis Cardiac
Heart Failure
Cardiac MRI
+3
ENROLLING BY INVITATION

NCT06976762

Near-Infrared Spectroscopy Measurements in Chronic Obstructive Pulmonary Disease

Participants were selected based on three groups: healthy, chronic obstructive pulmonary disease, and chronic renal disease. NIRS was used to measure tissue oxygenation on the thenar region of the right hand. A pressure cuff was used to temporarily occlude arterial inflow, thus allowing the response to this to be assessed. The StO2 was plotted against time, and the following variables were calculated, the downslope, upslope, area under curve.

Gender: All

Ages: 18 Years - 80 Years

Updated: 2025-05-16

Microcirculatory Status
Spectroscopic Analysis
COPD
+1